Our adventure began in Barcelona in 2003, when three friends in their twenties decided to start up in the pharmaceutical sector. At a time when the dotcoms were proliferating, Galenicum broke into a fairly traditional space.
Even though in the beginning, the business of Galenicum was limited to trading of active pharmaceutical ingredients (APIs) for generics’ companies in Spain, the activity very quickly expanded to encompass the full value chain, including: research and development, regulatory affairs, manufacturing and supply of a broad range of medicines in any part of the world.
Our positioning as ‘specialty pharma’ sums up our ambition in research and development, as well as in operations to fulfil our purpose: to keep improving the quality and affordability of medicines worldwide.
An entrepreneurial free-spirit along with a close, reliable and flexible service to clients, have driven our conscious growth since day one. Today, Galenicum is an ecosystem of several businesses with commercial presence in over 50 countries, covering the full pharmaceutical value chain.
‘The Grand Journey’ is the first episode of a trilogy of short films around the renovation of an old industrial warehouse, which has become the new Galenicum headquarters and R&D Center in 2022.